Anavex Life Sciences Corp.

AVXL US0327973006

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Annual Insiders Turnover, USD ²

¹ annual and historical performance metrics are recalculated on a daily basis;
² represents the total value of insider transactions (both buying and selling);

Insider Activity

Person	Price	Shares	Total	Published	Completed
Donhauser Peter D.o. O	3.64 USD	2,835 Bought	10,319 USD	14/06/2024	14/06/2024
Thomas Steffen O	4.52 USD	5,000 Bought	22,600 USD	15/05/2024	15/05/2024
Missling Christopher U CEO	5.11 USD	73,380 Sold	374,972 USD	28/03/2024	28/03/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Anavex Life Sciences Corp. to your watchlist and receive automatic alerts for upcoming transactions.

Generate

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

• Insider Transaction Amount Distribution
• Insider Trading Seasonality
• Delta Correlation Analysis

 

Last	52W Low	52W High	All-Time Low	All-Time High	β

Company Insiders

Person / Entity	Transactions	Turnover, USD	Average, USD	First	Last
Missling Christopher U	1	374,971.80	374,971.80	28/03/2024	28/03/2024
Thomas Steffen	1	22,600.00	22,600.00	15/05/2024	15/05/2024
Donhauser Peter D.o.	1	10,319.40	10,319.40	14/06/2024	14/06/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics

Delta Correlation	subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4	subscribe 🔒

⁴ represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

⁵ a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.